<p>At the European Society for Medical Oncology Congress 2022, Dr. Naoto Ueno presented patient-reported quality-of-life outcomes from the DESTINY-Breast04 study, which found that compared to doctors’ choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer.</p><p>Listen to the episode to her Dr. Ueno explain:</p><ul>
<li>how the researchers assessed quality of life</li>
<li>the results showing that Enhertu offered better quality of life than the doctors’ choice of chemotherapy</li>
<li>differences in side effects between Enhertu and chemotherapy</li>
</ul>

At the European Society for Medical Oncology Congress 2022, Dr. Naoto Ueno presented patient-reported quality-of-life outcomes from the DESTINY-Breast04 study, which found that compared to doctors’ choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer. Listen to the episode to her Dr. Ueno explain: how the researchers assessed quality of life the results showing that Enhertu offered better quality of life than the doctors’ choice of chemotherapy differences in side effects between Enhertu and chemotherapy

Enhertu for HER2-Low Breast Cancer: Patient-Reported Outcomes

New episodes publish every Tuesday at 5 a.m. ET.

Covering everything from the latest breast cancer treatments to the rising costs of care to what it’s like to be diagnosed when you’re pregnant, The Breastcancer.org Podcast explores all things breast cancer. Join host and veteran science reporter Jamie DePolo as she talks to world-renowned oncologists, breast cancer advocates, and everyday people affected by breast cancer. Guests have included oncologists Hope Rugo, Dennis Slamon, and Eleonora Teplinsky, as well as advocates from METAvivor, Breast Cancer Action, SHARE, and GRASP. The Breastcancer.org Podcast is produced by Breastcancer.org, a nonprofit organization dedicated to providing the most reliable and up-to-date information about breast cancer. Learn more about breast cancer and join our community at www.breastcancer.org.

Medicine

Health & Fitness

Education

New episodes publish every Tuesday at 5 a.m. ET. Covering everything from the latest breast cancer treatments to the rising costs of care to what it’s like to be diagnosed when you’re pregnant, The Breastcancer.org Podcast explores all things breast cancer. Join host and veteran science reporter Jamie DePolo as she talks to world-renowned oncologists, breast cancer advocates, and everyday people affected by breast cancer. Guests have included oncologists Hope Rugo, Dennis Slamon, and Eleonora Teplinsky, as well as advocates from METAvivor, Breast Cancer Action, SHARE, and GRASP. The Breastcancer.org Podcast is produced by Breastcancer.org, a nonprofit organization dedicated to providing the most reliable and up-to-date information about breast cancer. Learn more about breast cancer and join our community at www.breastcancer.org.

Share Enhertu for HER2-Low Breast Cancer: Patient-Reported Outcomes

Sign up to save your podcasts

Enhertu for HER2-Low Breast Cancer: Patient-Reported Outcomes

Enhertu for HER2-Low Breast Cancer: Patient-Reported Outcomes

More shows like Breastcancer.org Podcast

TED Radio Hour

Well Beyond 40

The mindbodygreen Podcast

Dr. Berg’s Healthy Keto and Intermittent Fasting Podcast

The Proof with Simon Hill

Dhru Purohit Show

The Dr. Hyman Show

Breast Cancer Conversations

Life Kit

This Is So Awkward

Dr. Streicher’s Inside Information: Menopause, Midlife, and More

The Mel Robbins Podcast

The Dr. Gabrielle Lyon Show

Keeping Abreast with Dr. Jenn

The Menopause and Cancer Podcast